Discover efficiency gains at healthcare delivery level for savings and outcomes improvements | European Pharmaceutical Pricing & Reimbursement

SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will feature presentations an array of big pharma, biotech and academia including EMIG, ABPI, EUCOPE, Quintiles, GSK, Sanofi Turkey, MSD, National Pharmaceutical Association Ltd and Myeloma UK, among others. End Quote

(1888PressRelease) May 29, 2015 - Recent advances in the sophistication of HTA analysis and modeling, flexible pay for performance models, risk-sharing and value-based pricing schemes have become increasingly important to mitigate payer risk and allocate financial resources to the areas of pressing need. Savings and outcome improvements can also be found through finding efficiency gains at the healthcare delivery level, providing the right incentives for prescribers and improving patient adherence.

Against this backdrop, SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will address these latest developments and provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies with an invaluable insight into the decision making processes and approaches of these vital stakeholders. The two-day conference programme will help further your understanding and enable you to develop best practice approaches to such vital and common challenges, with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications.

Key Speakers include:
• Leslie Galloway, Chairman, Ethical Medicines Industry Group
• Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
• Janice Haigh, Practice Leader Market Access, Quintiles
• Ken Walsh, Head Emerging Markets Pricing, GSK
• Toros Sahin, Head of Market Access & Health Economics, Sanofi Turkey
• David Watson, Director of Pricing & Reimbursement, ABPI
• Alexander Roediger, Director European Union Affairs, MSD
• Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
• Eric Low, CEO, Myeloma UK

View the full speaker line-up and conference programme at http://www.pharmaceuticalpricing.co.uk/1888pressrelease

Plus, don't miss the half-day interactive post-conference workshop:
HTA Uncovered
Led by Anke Van Engen, Principal - Advisory Services & Janice Haigh, Practice Leader Market Access, Quintiles
8.30 - 12.30, 7th October 2015, London, UK

###

space

Other Related Press Releases